South San Francisco, CA 8/4/16—Fluidigm, a provider of life science analytical and preparatory systems, has appointed Chris Linthwaite as president and COO. He will oversee sales, marketing, R&D, manufacturing and quality. Mr. Linthwaite previously served as president of Thermo Fisher Scientific’s Genetic Sciences Division. “Chris is a trusted leader with a reputation for developing high performing teams and delivering results,” stated Fluidigm CEO Gajus Worthington. “These attributes, in combination with his strategic abilities to identify and capitalize on market growth opportunities, will be force multipliers for Fluidigm and its customers.”

Mr. Worthington formerly served as both president and CEO, and Fred Walder was previously COO. Mr. Walder relinquished his title in October 2015. Prior to Life Technologies’ acquisition by Thermo Fisher (see IBO 4/15/13), Mr. Linthwaite served as president of Life’s BioProduction Division.